<?xml version="1.0" encoding="UTF-8"?>

<article>
<meta-data>
<journal-meta>
<journal-name>Obstetrics and Gynaecology Cases - Reviews</journal-name>
<journal-shortname>Obstet Gynecol Cases Rev</journal-shortname>
<journal-doi>10.23937/2377-9004</journal-doi>
<issn>2377-9004</issn>
<publisher>
<publisher-name>ClinMed International Library</publisher-name>
<publisher-location>Wilmington, USA</publisher-location>
<publisher-doi-prefix>10.23937</publisher-doi-prefix>
</publisher>
</journal-meta>
<article-meta>
<article-title>
Preeclampsia Combined with Posterior Reversible Encephalopathy Syndrome: A Case Report
</article-title>
<citation_author>Xiong XY</citation_author>
<article-doi>10.23937/2377-9004/1410277</article-doi>
<article-description>
Posterior reversible encephalopathy syndrome (PRES) is a rare clinical radiological syndrome. It has low morbidity and high mortality, especially in preeclampsia (PE) patients. Because the clinical symptoms and signs of PRES have no significant specificity, the diagnosis mainly relies on imaging examination, which is prone to misdiagnosis and missed diagnosis. This case reported a maternal with severe PE who developed PRES after delivery. Early differential diagnosis using a combination of initial imaging and auxiliary investigations can facilitate timely diagnosis and treatment, thereby improving clinical outcomes.
</article-description>
</article-meta>
</meta-data>
<body>
<article-type>Case Report</article-type>
<volume>13</volume>
<issue>2</issue>
<access-type>OPEN ACCESS</access-type>
<article-doi>10.23937/2377-9004/1410277</article-doi>
<article-title>
Preeclampsia Combined with Posterior Reversible Encephalopathy Syndrome: A Case Report
 
</article-title>
<Author-Group>
<aut id="aut1">
<label>Author-1</label>
<name>Xian yan Xiong</name>
<affiliation>
Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, China
</affiliation>
</aut>
<aut id="aut2">
<label>Author-2</label>
<name>Jing Wu</name>
<affiliation>
Department of Critical Care Medicine, Guizhou Provincial People's Hospital, Guiyang 550000, China
</affiliation>
</aut>
</Author-Group>
<author-notes>
<corres-author>
<label>Corresponding-Author</label>
<name>Jing Wu</name>
<address>
 Department of Critical Care Medicine, Guizhou Provincial People’s Hospital, Guiyang 550000, China, Tel: 13984376424.
</address>
</corres-author>
</author-notes>
<history>
<published-date>
<day>24</day>
<month>October  </month>
<year>2026</year>
</published-date>
</history>
<citation>
<author-names>
Xiong XY, Wu J
</author-names>
<published-year>2026</published-year>
<article-title>
Preeclampsia Combined with Posterior Reversible Encephalopathy Syndrome: A Case Report
</article-title>
<journal-short-name>Obstet Gynecol Cases Rev</journal-short-name>
<article-doi>10.23937/2377-9004/1410277</article-doi>
</citation>
<permissions>
<copyright>
<copyright-year>2026</copyright-year>
<copyright-holder>Xiong XY, et al. </copyright-holder>
<copyright-notes>
© This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
</copyright-notes>
</copyright>
</permissions>
<article-content>



<p>
	Abstract
	<br />
	Posterior reversible encephalopathy syndrome (PRES) is a rare clinical radiological syndrome. It has low morbidity and high mortality, especially in preeclampsia (PE) patients. Because the clinical symptoms and signs of PRES have no significant specificity, the diagnosis mainly relies on imaging examination, which is prone to misdiagnosis and missed diagnosis. This case reported a maternal with severe PE who developed PRES after delivery. Early differential diagnosis using a combination of initial imaging and auxiliary investigations can facilitate timely diagnosis and treatment, thereby improving clinical outcomes.
</p>
<p>
	Keywords
	<br />
	Posterior reversible encephalopathy syndrome (PRES), Preeclampsia, Case report
</p>
<p>
	Introduction
	<br />
	Posterior reversible encephalopathy syndrome（PRES）is an acute or subacute clinical-radiological syndrome, first described by Hinchey et al in 1996 [1]. It is characterized by a variety of neurological symptoms, such as headache, visual impairment or visual field defects, impaired consciousness, seizures and focal neurological deficits [2,3]. Imaging findings typically demonstrate reversible vasogenic cerebral edema, with posterior circulation involvement being predominant [4]. Because clinical symptoms and signs are nonspecific, diagnosis depends mainly on imaging examinations. To date, the exact pathogenesis of PRES remains unclear. It has been reported to be associated with a variety of conditions, including acute hypertensive encephalopathy, renal failure, sepsis, autoimmune diseases, thrombotic thrombocytopenic purpura, HIV infection, and acute intermittent porphyria [5]. A retrospective cohort study has reported that the age and sex standardized annual incidence of PRES in the United States is approximately 0.003%. The condition can occur across all age groups, with a particular predominance in young and middle-aged adults, and is more prevalent in females than in males [6]. The median length of hospital stay for patients with PRES was 12 days; 68.3% required admission to an intensive care unit (ICU), and 33.3% needed mechanical ventilation [7]. Following symptomatic treatment, the overall prognosis was favorable. The clinical symptoms and imaging abnormalities in most patients resolve completely within days to weeks. However, 10-20% of cases may develop permanent neurological sequelae [8], with an overall mortality rate of approximately 3-6% [9]. Patients with residual neurological sequelae can be assessed using the Barthel Index, which measures activities of daily living. The scale consists of 10 items: feeding, bathing, grooming, dressing, bowel and bladder control, toileting, bed to chair transfer, level walking, and stair climbing. The summed total score classifies patients according to their self-care ability: severe dependence (&#38;le; 40 points), moderate dependence (41-60 points), mild dependence (61-99 points), and functional independence (100 points).
</p>
<p>
	Preeclampsia (PE), also known as toxemia of pregnancy, is a multisystem gestational disorder characterized by new-onset hypertension developing after 20 weeks of gestation, accompanied by proteinuria and/or end-organ dysfunction [10,11]. It occurs more frequently in women with advanced maternal age, first pregnancy, a personal or family history of PE, obesity, prolonged interpregnancy intervals, and conception via assisted reproductive technology. Its primary clinical manifestations include hypertension and proteinuria, which may be complicated by multiorgan dysfunction, such as headache, nausea, vomiting, abdominal pain, dyspnea, jaundice, oliguria, anuria, and seizures. Based on the gestational age at onset and the presence of end organ involvement, PE is classified as early onset (&#38;lt; 34 +0 weeks of gestation) or late onset (&#38;ge; 34 weeks of gestation) [12,13]; mild (without end organ involvement) and severe (with end organ damage or dysfunction). Common maternal complications include eclampsia, HELLP syndrome, cerebrovascular events, acute kidney injury, pulmonary edema, and disseminated intravascular coagulation. Fetal and neonatal complications include fetal growth restriction, placental abruption, preterm birth, fetal distress, and stillbirth, all of which substantially compromise maternal and fetal safety.
</p>
<p>
	PE complicated by PRES is extremely rare. Owing to unique hemodynamic alterations during pregnancy, these patients exhibit markedly accelerated disease progression and a substantially higher risk of adverse maternal and fetal outcomes. According to epidemiological data, the overall prevalence of PE ranges from 3% to 7% [14]. The condition accounts for approximately 14% of global maternal deaths and 10-25% of perinatal deaths [15]. This report describes a typical clinical case of PE complicated by PRES.
</p>
<p>
	Case Presentation
	<br />
	A 31-year-old multiparous woman with a body mass index (BMI) of 27.1 kg/m 2 was admitted to our hospital. She was admitted with a chief complaint of altered mental status for more than 2 days following delivery. The patient&#38;rsquo;s antenatal course was uneventful, with regular follow-up and no abnormal findings. At 34+3 weeks of gestation, the patient presented with headache, dizziness, blurred vision, limb weakness, nausea, and vomiting without obvious precipitating factors. This clinical presentation was consistent with the onset of severe PE. She was found to have a blood pressure of 180/128 mmHg, serum creatinine of 148 &#38;mu;mol/L, and urinary protein (4+) measured at an outside hospital. The patient was diagnosed with severe PE and acute renal impairment. Symptomatic treatment was administered, including antihypertensive therapy with sustained release nifedipine and labetalol, Magnesium sulfate contributes to the relief of vasospasm，and sedation with diazepam. An emergency cesarean section was performed under general anesthesia at 34 +5 weeks of gestation. The operation lasted 60 minutes, with an intraoperative blood loss of 200 mL. Her vital signs remained stable throughout the procedure. A male infant was delivered weighing 1500 g, with Apgar scores of 5 at 1 minute, 7 at 5 minutes, and 8 at 10 minutes after birth. Following delivery, owing to persistent severe PE, the patient was transferred to the intensive care unit with an endotracheal tube in place for further management. At 20 hours after delivery, the patient was awake, oriented, and compliant with commands, with stable oxygenation and hemodynamics. Therefore, endotracheal extubation was performed. One hour following extubation, the patient developed altered mental status and restlessness accompanied by refractory hypoxemia, requiring repeated endotracheal intubation and mechanical ventilation. An emergency cranial computed tomography scan revealed hypodense lesions involving the bilateral frontoparietal and occipital lobes, along with a rounded hypodense area in the right frontal lobe. A preliminary diagnosis was established as altered mental status secondary to a suspected cerebrovascular event or other underlying disorders. Conventional interventions, including antihypertensive, antispasmodic, and sedative therapies, demonstrated limited efficacy. Given the unclear etiology of her clinical manifestations, the patient was transferred to our hospital for further evaluation and management. Past medical history: The patient had no preexisting chronic conditions, including hypertension, diabetes mellitus, or glomerulonephritis. She was gravida 4, para 3 (G4P3), with unremarkable prior obstetric histories. No abnormalities were identified in her personal or family history.
</p>
<p>
	On admission, the patient&#38;rsquo;s vital signs were as follows: body temperature 36.7&#38;deg;C, heart rate 98 beats/min, respiratory rate 21 breaths/min, and blood pressure 167/128 mmHg. The patient was in a deep coma, with a Glasgow Coma Scale score of 2T (1 point for eye opening, 1 point for motor response, and T indicating no evaluable verbal response due to endotracheal intubation). Bilateral pupils were equal, round, and reactive to no light, with a diameter of 3.5 mm and the neck was supple. The patient was endotracheally intubated and maintained on mechanical ventilation. She exhibited symmetrically reduced muscle tone in all extremities. Superficial and deep sensations were absent, physiological reflexes were attenuated, and no pathological reflexes could be evoked.
</p>
<p>
	Auxiliary examination: Laboratory tests revealed markedly elevated inflammatory markers and D-dimer levels (Tables 1 and 2). There were significantly elevated hepatic and renal function parameters (particularly creatinine), mildly increased bilirubin, reduced albumin, and 2+ urinary protein (Tables 1 and 2). Blood ammonia levels, antineutrophil cytoplasmic antibodies (ANCA), antinuclear antibodies, and anticardiolipin antibodies were all negative. Given hypodense lesions involving the bilateral frontoparietal and occipital lobes on outside cranial CT, impaired consciousness was initially presumed to result from ischemic stroke. Electrocardiography (ECG), extremity vascular ultrasonography, and transthoracic echocardiography were performed to identify potential cardiac sources of embolism, evaluate systemic atherosclerotic burden, assess cardiac function, and rule out other cardioembolic causes of ischemic stroke.However, no significant abnormalities were observed in any of the aforementioned examinations. Follow-up cranial CT was performed to assess dynamic changes in intracranial lesions, detect hemorrhagic transformation, and rule out other acute intracranial pathologies. Non-contrast three-dimensional cranial CT revealed that attenuation and mild swelling of the cerebral parenchyma in both cerebral hemispheres (Figure 1), without definite infarctive lesions, which precluded a definitive diagnosis of cerebral infarction. In view of the elevated inflammatory markers, encephalitis/meningitis, Guillain-Barr&#38;eacute; syndrome, and demyelinating lesions could not be excluded. Cerebrospinal fluid routine analysis (Table 3) and biochemical testing (Table 4) were therefore performed. Encephalitis, meningitis, Guillain-Barr&#38;eacute; syndrome, and demyelinating lesions were subsequently excluded. Electroencephalography (EEG) demonstrated abnormal findings, characterised by a diffusely abnormal background dominated by widespread slow-wave activity across all regions, with preserved normal rhythms absent and no identifiable sleep-wake cycles. Paroxysmal and periodic background abnormalities were noted across all cerebral regions, with a predominant distribution in the frontal lobes. Diffuse, intermittent attenuation of amplitude was noted across all channels during sleep. Asynchronous epileptiform discharges were additionally identified in the bilateral frontal and temporal regions (Figure 2). Brainstem auditory evoked potentials indicated central nervous system impairment, involving the limb proprioceptive pathways, bilateral brainstem auditory pathways, and bilateral visual pathways. These findings indicated central nervous system involvement, although a definite etiological and localized diagnosis could not be established. Despite comprehensive management, including endotracheal intubation with mechanical ventilation, hemodynamic stabilization, eclampsia prophylaxis, dehydrative intracranial pressure reduction, and neuroprotective awakening therapy, the patient exhibited persistent impaired consciousness, and the underlying etiology remained unconfirmed. Following tracheotomy, cranial magnetic resonance imaging (MRI) identified bilateral cerebral abnormal signals consistent with PRES (Figure 3). No intracranial venous sinus thrombosis was detected on magnetic resonance venography (MRV). Based on the patient&#38;rsquo;s clinical history, physical examination, and auxiliary investigations including cranial computed tomography, magnetic resonance imaging, and EEG, the final diagnoses were made.The diagnoses included severe PE complicated by PRES, status post cesarean section, and acute kidney injury.
</p>
<p>
	Figure 1: Cranial CT revealed low-density lesions in the bilateral frontal, parietal and occipital lobes. View Figure 1
</p>
<p>
	Figure 2: EEG showed diffuse abnormalities in the background activity, characterized by diffuse slow-wave activity over the entire head. View Figure 2
</p>
<p>
	Figure 3: Cranial MRI findings. (A): T1-weighted imaging demonstrated isointense to slightly hyperintense signals within the bilateral cerebral hemispheres; (B): On T2-weighted imaging, slightly hyperintense signals were observed in the bilateral cerebral hemispheres; (C): On FLAIR sequences, marked hyperintense signals were predominantly observed in the posterior cerebral regions; (D): On high b-value DWI, mild hyperintense signals were noted within the bilateral cerebral hemispheres. View Figure 3
</p>
<p>
	Table 1: Blood routine, urine routine and coagulation function. View Table 1
</p>
<p>
	Table 2: Serum biochemistry. View Table 2
</p>
<p>
	Table 3: Routine cerebrospinal fluid examination. View Table 3
</p>
<p>
	Table 4: Cerebrospinal fluid biochemistry. View Table 4
</p>
<p>
	The patient received comprehensive management, including endotracheal intubation combined with mechanical ventilation, mild hypothermia for cerebral protection, antihypertensive therapy, magnesium sulfate for postpartum eclampsia prophylaxis, sodium valproate for seizure prevention, Xingnaojing injection to promote consciousness recovery, glutamine to improve cerebral metabolism, mannitol for dehydration and intracranial pressure reduction, nimodipine for the prevention of cerebral vasospasm, as well as hyperbaric oxygen, acupuncture, and rehabilitation therapy.
</p>
<p>
	Prognosis
	<br />
	Following comprehensive intervention, the patient gradually regained consciousness on postoperative day 57. Neurological examination revealed muscle strengths of grade 2 in the left extremities and grade 1 in the right extremities. On postoperative day 67, the muscle strength improved to grade 3 in the left extremities, whereas no neurological improvement was observed in the right extremities. Subsequently, the patient&#38;rsquo;s family requested hospital discharge for continued home rehabilitation and supportive care. At the 4 month postoperative follow up, the patient exhibited grade 4 muscle strength in the left extremities and grade 3+ muscle strength in the right extremities. The patient achieved a Barthel Index score of 45, indicating moderate functional disability and substantial dependence in activities of daily living.
</p>
<p>
	Discussion
	<br />
	The pathogenic mechanisms underlying PE and PRES are highly overlapping, encompassing cerebrovascular dysregulation-mediated vasogenic edema, cytotoxicity-related disruption of the blood&#38;ndash;brain barrier, and generalized endothelial dysfunction. In the present case, the patient developed hypertension during the second trimester. Two days before delivery, she presented with proteinuria, renal impairment, headache, dizziness, blurred vision, extremity weakness, nausea, and vomiting. Her postoperative neurological manifestations were consistent with the typical clinical features of PE complicated by PRES. Given the substantial overlap in their pathogenic mechanisms, adequate pathophysiological evidence supports the concomitant occurrence of PRES in patients with PE.
</p>
<p>
	Owing to its nonspecific clinical manifestations, the diagnosis of PRES relies primarily on neuroimaging findings. The main findings on head CT included symmetric extensive hypodense lesions in the white matter of both cerebral hemispheres, and PRES was identified in approximately half of the cases [16]. MRI represents the gold standard for the diagnosis of PRES. However, most existing studies are retrospective and based on small sample sizes, and radiographic interpretation relies heavily on subjective experience among radiologists. Accordingly, robust and standardized data regarding the sensitivity and specificity of MRI for PRES remain lacking. On MRI, characteristic findings consisted of predominant white matter lesions involving the posterior cerebral regions. The lesions demonstrated hypointense signals on T1-weighted imaging, hyperintense signals on T2-weighted imaging and FLAIR, iso- to mildly hyperintense signals on DWI, and variable signals (iso-, mildly hyperintense, or hypointense) on ADC mapping [17]. The parietal and occipital lobes represent the most frequently affected regions. Common EEG findings in patients with PRES include generalized or posterior focal cerebral slowing, which may be accompanied by epileptiform discharges [1,18,19]. In the present case, cranial CT demonstrated hypodense lesions involving the bilateral frontal, parietal, and occipital lobes. On MRI, bilateral cerebral lesions exhibited iso to mildly hyperintense signals on T1-weighted imaging, mildly hyperintense signals on T2-weighted imaging, marked hyperintensity on FLAIR, and mild hyperintensity on DWI, without definitive abnormal hypointense changes on ADC mapping. Both CT and MRI identified vasogenic edema, and the overall imaging characteristics and anatomical distribution were consistent with typical findings of PRES. EEG demonstrated diffuse background abnormalities predominated by generalized slow-wave activity, along with asynchronous bilateral epileptiform discharges involving the frontal and temporal lobes, consistent with classic electrographic alterations described in PRES.
</p>
<p>
	There are currently no targeted therapeutic interventions for PE aside from blood pressure control, eclampsia prophylaxis, and timely termination of pregnancy. Similarly, no targeted therapeutic strategies are available for PRES, and clinical management primarily focuses on prompt elimination of predisposing factors and supportive symptomatic treatment. In the present case, the patient was diagnosed with PE complicated by superimposed PRES. Therapeutic interventions included aggressive blood pressure control, sedation, antispasmodic therapy, intracranial pressure reduction, alleviation of cerebral edema, timely termination of pregnancy, and supportive management to facilitate neurological recovery. PRES is reversible within days to weeks and associated with a favorable prognosis. A small proportion of patients may develop permanent neurological sequelae or even succumb to death. Although the patient in the present case has achieved full recovery of consciousness, she continues to experience residual motor dysfunction and remains dependent in activities of daily living. Patients with preeclampsia complicated by PRES exhibit greater disease severity and a worse prognosis compared with patients with isolated PRES. Owing to overlapping pathogenic mechanisms, patients may develop more severe impairment of intracranial vascular autoregulation.
</p>
<p>
	Conclusion
	<br />
	Patients with PE are at substantially elevated risk of developing PRES. However, the clinical manifestations of PRES are often nonspecific and may overlap with those of other neurological conditions, thereby increasing the likelihood of misdiagnosis and missed diagnosis. Delayed intervention may result in persistent neurological sequelae or fatal outcomes. Accordingly, early recognition and standardized management are critical for preventing severe complications and optimizing the long term prognostic outcome.
</p>
<p>
	Funding
	<br />
	The Guizhou Provincial Science and Technology Projects, No. QKH JC-ZK [2022]-260; The Guizhou Provincial High level Innovative Talent Fund, NO.gzwjrs2023-005
</p>
<p>
	Author Contributions
	<br />
	Jing Wu proposed the topic and was responsible for manuscript revision, Funding acquisition; Xianyan Xiong was responsible for case data collection, data sorting, literature retrieval, and manuscript writing.
</p>
<p>
	Conflicts of Interest
	<br />
	The authors declare no conflicts of interest.
</p>
<p>
	Acknowledgments
	<br />
	Thank you for your time and consideration. We sincerely hope that our manuscript will be of interest to the readers of Journal of Medical Case Reports.
</p>
<p>
	Declarations
	<br />
	Ethical approval and consent to pariticipate
</p>
<p>
	Ethics approval was granted by the Medical Ethics Committee of the Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine(Approval No: LW20250926). Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.
</p>
<p>
	Consent for Publication
	<br />
	This manuscript is original, has not been published previously, and is not under consideration for publication elsewhere. All authors have reviewed and approved the final manuscript and agree with its submission to Journal of Medical Case Reports.
</p>
<p>
	Availability of Data and Materials
	<br />
	The raw data supporting the findings of this study are available from the corresponding author upon reasonable request. The dataset is not publicly accessible due to patient privacy and ethical constraints, as it contains identifiable clinical and personal information.
</p>
<p>
	&#38;nbsp;
</p>



<figures-and-tables>
	<text>All Figures and Tables link given in below</text>
	<link>https://clinmedjournals.org/articles/ogcr/obstetrics-and-gynaecology-cases-reviews-ogcr-13-277.php?jid=ogcr</link>
</figures-and-tables>



</article-content>

<article-references>
<title>References</title>

		 
<ref id="ref1">
    <label>Reference-1</label>
    <mixed-citation>
					Hinchey J, Chaves C, Appignani B, Breen J, Pao L, et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494-500.
				    https://pubmed.ncbi.nlm.nih.gov/8559202/
    </mixed-citation>
</ref>
<ref id="ref2">
    <label>Reference-2</label>
    <mixed-citation>
					Gewirtz AN, Gao V, Parauda SC, Robbins MS (2021) Posterior reversible encephalopathy syndrome. Curr Pain Headache Rep 25: 19.
				    https://pmc.ncbi.nlm.nih.gov/articles/PMC7905767/
    </mixed-citation>
</ref>
<ref id="ref3">
    <label>Reference-3</label>
    <mixed-citation>
					Triplett JD, Kutlubaev MA, Kermode AG, Hardy T (2022) Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol 22: 183-189.
				    https://pubmed.ncbi.nlm.nih.gov/35046115/
    </mixed-citation>
</ref>
<ref id="ref4">
    <label>Reference-4</label>
    <mixed-citation>
					Anderson RC, Patel V, Sheikh-Bahaei N, Liu CSJ, Rajamohan AG, et al. (2020) Posterior reversible encephalopathy syndrome (PRES): Pathophysiology and neuro-imaging. Front Neurol 11: 463.
				    https://pubmed.ncbi.nlm.nih.gov/32612567/
    </mixed-citation>
</ref>
<ref id="ref5">
    <label>Reference-5</label>
    <mixed-citation>
					Behera CK, Jain MK, Mishra R, Jena PK, Dash SK, et al. (2020) Clinico-radiological profile of posterior reversible encephalopathy syndrome and its associated risk factors in PICU: A single-center experience from a tertiary care hospital in Bhubaneswar, Odisha. Indian J Crit Care Med 24: 1223-1229.
				    https://pubmed.ncbi.nlm.nih.gov/33446977/
    </mixed-citation>
</ref>
<ref id="ref6">
    <label>Reference-6</label>
    <mixed-citation>
					Otite FO, Patel SD, Anikpezie N, Hoffman H, Beutler T, et al. (2023) Demographic disparities in the incidence, clinical characteristics, and outcome of posterior reversible encephalopathy syndrome in the United States. Neurology 101: e1554-e1559.
				    https://pubmed.ncbi.nlm.nih.gov/37487751/
    </mixed-citation>
</ref>
<ref id="ref7">
    <label>Reference-7</label>
    <mixed-citation>
					Hiremath SB, Massicotte-Tisluck K, Chakraborty S (2022) Factors affecting hospitalization, imaging severity, and complications in posterior reversible encephalopathy syndrome. Neurol Sci 43: 6461-6470.
				    https://pubmed.ncbi.nlm.nih.gov/35852658/
    </mixed-citation>
</ref>
<ref id="ref8">
    <label>Reference-8</label>
    <mixed-citation>
					Frick D, Huecker M, Shoff H (2017) Posterior reversible encephalopathy syndrome presenting as stroke mimic. Clin Pract Cases Emerg Med 1: 171-174.
				    https://pubmed.ncbi.nlm.nih.gov/29849301/
    </mixed-citation>
</ref>
<ref id="ref9">
    <label>Reference-9</label>
    <mixed-citation>
					Moon SN, Jeon SJ, Choi SS, Song CJ, Chung GH, et al. (2013) Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?. Acta Radiol 54: 1182-1190.
				    https://pubmed.ncbi.nlm.nih.gov/23858507/
    </mixed-citation>
</ref>
<ref id="ref10">
    <label>Reference-10</label>
    <mixed-citation>
					Tanner MS, Davey MA, Mol BW, Rolnik DL (2022) The evolution of the diagnostic criteria of preeclampsia-eclampsia. Am J Obstet Gynecol 226: S835-S843.
				    https://pubmed.ncbi.nlm.nih.gov/35177221/
    </mixed-citation>
</ref>
<ref id="ref11">
    <label>Reference-11</label>
    <mixed-citation>
					Vidaeff AC, Saade GR, Sibai BM (2021) Preeclampsia: The need for a biological definition and diagnosis. Am J Perinatol 38: 976-982.
				    https://pubmed.ncbi.nlm.nih.gov/31986536/
    </mixed-citation>
</ref>
<ref id="ref12">
    <label>Reference-12</label>
    <mixed-citation>
					Shankar P, Karthikeyan K, Nalini AP, Sindhura M, Kim G (2019) Maternofetal outcomes in early versus late onset pre-eclampsia: a comparative study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 8: 548-551.
				    https://www.ijrcog.org/index.php/ijrcog/article/view/5922
    </mixed-citation>
</ref>
<ref id="ref13">
    <label>Reference-13</label>
    <mixed-citation>
					Gulec UK, Ozgunen FT, Buyukkurt S, Guzel AB, Urunsak IF, et al. (2013) Comparison of clinical and laboratory findings in early- and late-onset preeclampsia. J Matern Fetal Neonatal Med 26: 1228-1233.
				    https://pubmed.ncbi.nlm.nih.gov/23413799/
    </mixed-citation>
</ref>
<ref id="ref14">
    <label>Reference-14</label>
    <mixed-citation>
					Enkhmaa D, Wall D, Mehta PK, Stuart JJ, Rich-Edwards JW, et al. (2016) Preeclampsia and vascular function: A window to future cardiovascular disease risk. J Womens Health 25: 284-291.
				    https://pmc.ncbi.nlm.nih.gov/articles/PMC4790201/
    </mixed-citation>
</ref>
<ref id="ref15">
    <label>Reference-15</label>
    <mixed-citation>
					Bokuda K, Ichihara A (2023) Preeclampsia up to date-What's going on? Hypertens Res 46: 1900-1907.
				    https://pubmed.ncbi.nlm.nih.gov/37268721/
    </mixed-citation>
</ref>
<ref id="ref16">
    <label>Reference-16</label>
    <mixed-citation>
					Roth C, Ferbert A (2010) Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry 81: 773-777.
				    https://pubmed.ncbi.nlm.nih.gov/19955114/
    </mixed-citation>
</ref>
<ref id="ref17">
    <label>Reference-17</label>
    <mixed-citation>
					Shen T, Chen H, Jing J, Raza HK, Zhang Z, et al. (2019) A study on clinical characteristics and the causes of missed diagnosis of reversible posterior leukoencephalopathy syndrome in eclampsia. Neurol Sci 40: 1873-1876.
				    https://pubmed.ncbi.nlm.nih.gov/31062190/
    </mixed-citation>
</ref>
<ref id="ref18">
    <label>Reference-18</label>
    <mixed-citation>
					Yeshokumar AK, Coughlin A, Fastman J, Psaila K, Harmon M, et al. (2021) Seizures in autoimmune encephalitis-A systematic review and quantitative synthesis. Epilepsia 62: 397-407.
				    https://pubmed.ncbi.nlm.nih.gov/33475161/
    </mixed-citation>
</ref>
<ref id="ref19">
    <label>Reference-19</label>
    <mixed-citation>
					Endres D, Leypoldt F, Bechter K, Hasan A, Steiner J, et al. (2020) Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: Clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. Eur Arch Psychiatry Clin Neurosci 270: 803-818.
				    https://pubmed.ncbi.nlm.nih.gov/32166503/
    </mixed-citation>
</ref>


</article-references>
</body>
</article>